Valiant Laboratories Limited is an India-based pharmaceutical ingredient manufacturing company. The Company is focused on manufacturing a Paracetamol active pharmaceutical ingredient (API)/bulk drug. It has several applications in the treatment of conditions such as headache, muscle ache, arthritis, backache, toothache, cold and fever. It is also used in the management of severe pain such as post-surgical and cancer pain. It operates a single-location manufacturing facility on the Tarapur industrial estate.

Employees

Sector

Specialty Chemicals

More about the company

Quotes

Date	Price	Change	Volume
10/07/26	₹62.08	-0.13%	15,706
09/07/26	₹62.16	-2.66%	13,893
08/07/26	₹63.86	-0.58%	16,447
07/07/26	₹64.23	-1.95%	20,234
06/07/26	₹65.51	+0.77%	8,743

End-of-day quote NSE India S.E.

More quotes

Income Statement and Estimates

More financial data

End-of-day quote NSE India S.E. Other stock markets 10/07/2026			5-day change	1st Jan Change
62.08 ^INR	-0.13%		-4.51%	-11.31%

05-20	Valiant Organics Limited agreed to acquire 34.26% stake in Valiant Laboratories Limited from Dhanvallabh Ventures LLP.	CI
05-14	Valiant Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI

Market Cap	2.8B 29.4M 25.71M 23.72M 21.9M 41.56M 42.26M 283M 111M 1.38B 110M 108M 4.75B	P/E 2024	1,725x	P/E 2025	-150x
Enterprise Value	3.26B 34.14M 29.87M 27.55M 25.44M 48.28M 49.09M 329M 129M 1.6B 128M 125M 5.52B	EV / Sales 2024	3.09x	EV / Sales 2025	2.83x
Free-Float	23.77%	Yield 2024 *	-	Yield 2025	-

05-20	Valiant Organics Limited agreed to acquire 34.26% stake in Valiant Laboratories Limited from Dhanvallabh Ventures LLP.	CI
05-14	Valiant Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
04-23	Valiant Laboratories Limited Announces Resignation of Bhanudas D. Patil as Q.C Manager, Senior Management Personnel, Effective April 22, 2026	CI
02-11	Valiant Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
01-15	Valiant Laboratories Ltd receives notice for total tax demand of approx. 125.3 million rupees	RE
11-11	Valiant Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
11-07	Valiant Laboratories Arm Begins Commercial Operations at New Unit in Gujarat, India; Shares Up 4%	MT
25/09/25	Valiant Laboratories Limited Approves Change in Designation of Paresh Shah from Executive Director to Whole-Time Director, Effective September 25, 2025	CI
08/08/25	Valiant Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025	CI
16/07/25	Valiant Laboratories Gets Board Nod for INR815 Million Rights Issue; Shares Up 4%	MT
15/07/25	Valiant Laboratories says rights issue price set at 75 rupees per share, entitlement ratio 1:4	RE
09/07/25	Valiant Laboratories approves rights issue up to 814.7 mln rupees	RE
09/07/25	Valiant Laboratories Gets Board Nod to Raise Up To INR815 Million Through Rights Issue	MT

1 day	-0.13%
1 week	-4.51%
Current month	-4.49%
1 month	-7.38%
3 months	+6.34%
6 months	-7.61%
Current year	-11.31%

Valiant Laboratories Limited Stock

Stocks

VALIANTLAB

INE0JWS01017

Specialty Chemicals

Valuation: Valiant Laboratories Limited

Chart: Valiant Laboratories Limited

Latest news : Valiant Laboratories Limited

Quotes and Performance

Course Extremes

Managers and Directors: Valiant Laboratories Limited

Other Specialty Chemicals

Financials

Company Profile

Quotes

Income Statement and Estimates

1 week	60.17	66
1 month	60.17	70.95
Current year	49.51	83.7
1 year	49.51	123.88
3 years	49.51	214.95
5 years	49.51	214.95
10 years	49.51	214.95

Manager	Title	Age	Since
Santosh Vora CEO	Chief Executive Officer	32	21/08/2021
Paresh Shah DFI	Director of Finance/CFO	66	16/08/2021
Akshay Dnyaneshwar Gangurde CMP	Compliance Officer	-	09/07/2025

Director	Title	Age	Since
Santosh Vora BRD	Director/Board Member	32	21/08/2021
Sonal Amit Vira BRD	Director/Board Member	43	16/02/2022
Paresh Shah BRD	Director/Board Member	66	16/08/2021

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
VALIANT LABORATORIES LIMITED	-0.13%	-4.51%	-44.62%	-	35.35M
ECOLAB INC.	+0.47%	-3.19%	+2.75%	+48.55%	77.2B
GIVAUDAN SA	+0.41%	-2.11%	-9.42%	+15.75%	39.27B
SIKA AG	+0.99%	-6.81%	-21.00%	-36.00%	32.36B
FUJIFILM HOLDINGS CORPORATION	+0.73%	-0.97%	+19.22%	+30.92%	26.33B
SOCIEDAD QUÍMICA Y MINERA DE CHILE S.A.	-1.21%	+0.67%	+94.50%	-7.86%	20.91B
EMS-CHEMIE HOLDING AG	+4.24%	+2.22%	+10.88%	+4.08%	20.68B
DUPONT DE NEMOURS, INC.	-0.08%	-3.74%	-40.53%	-37.07%	18.18B
ALBEMARLE CORPORATION	-1.85%	-7.02%	+77.59%	-47.28%	14.87B
SYMRISE AG	+0.07%	-3.02%	-1.20%	-6.28%	13.94B
Average	+0.36%	-2.80%	+8.82%	-3.91%	26.38B
Weighted average by Cap.	+0.52%	-2.67%	+8.60%	+9.37%

	2024	2025
Net sales	1.82B 19.09M 16.7M 15.4M 14.22M 26.99M 27.44M 184M 72.26M 897M 71.67M 70.11M 3.08B	1.33B 13.99M 12.23M 11.28M 10.42M 19.77M 20.11M 135M 52.94M 657M 52.51M 51.37M 2.26B
Net income	3.2M 33.51K 29.31K 27.04K 24.97K 47.38K 48.18K 323K 127K 1.57M 126K 123K 5.41M	-22.01M -231K -202K -186K -172K -326K -332K -2.22M -874K -10.84M -867K -848K -37.28M
Net Debt	-671M -7.04M -6.16M -5.68M -5.24M -9.95M -10.12M -67.84M -26.64M -331M -26.42M -25.85M -1.14B	453M 4.75M 4.15M 3.83M 3.54M 6.71M 6.83M 45.78M 17.98M 223M 17.83M 17.44M 767M